HK Stock MarketDetailed Quotes

09960 KINDSTAR GLOBAL

Watchlist
  • 1.170
  • +0.010+0.86%
Market Closed Jan 3 16:08 CST
1.14BMarket Cap117.00P/E (TTM)

About KINDSTAR GLOBAL Company

Kangsheng Global Gene Technology Co., Ltd. (hereinafter referred to as “Kangsheng Global”) is a large-scale high-end medical specialist testing service testing group in China. It is committed to leading the advancement of specialist testing technology and services in China and promoting the development and improvement of specialist diagnosis and personalized medicine in China. In line with the purpose of putting patients' interests first and doctors' needs first, Kangsheng Global follows international norms, standards and industry guidelines, introduces and develops the world's most advanced technology and specialist testing methods, and provides comprehensive, advanced and accurate specialist examination services to China's large tertiary hospitals, specialist hospitals, and general hospitals. Kangsheng Global has built 38,000 square meters of internationally advanced clinical testing, scientific research cooperation and application R&D laboratories in Beijing, Shanghai, Wuhan, Xinjiang, Chengdu and Tianjin. It has high-resolution flow (FCM) testing platforms, PCR (real-time PCR) platforms, gene chip platforms (Affymetrix), liquid chip platforms (Luminex), DNA mass spectrometry (Sequenom), digital gene platforms (nanoString), sequencing platforms, cytogenetic platforms (karyotype analysis, FISH, etc.), mass spectrometry platforms, clinical immunology platforms, clinical immunology platforms, clinical chemistry platforms, etc., provide more than 3,000 hospitals in 31 provincial municipalities and more than 600 cities, especially more than 1,000 large tertiary hospitals, with more than 3,000 high-precision diagnostic tests in fields such as hematology, tumors, genetics, cardiovascular, infectious diseases, autoimmune diseases, etc., and specialized internal, external, maternal, and pediatric diseases. Through cooperation with the world's top medical technology institutions and major pharmaceutical companies, they provide medical research, drug testing, and translational medicine to clinicians across the country Research services.

Company Profile

Symbol09960
Company NameKINDSTAR GLOBAL
ISINKYG5262E1044
Listing DateJul 16, 2021
Issue Price9.78
Shares Offered226.41M share(s)
FoundedAug 24, 2007
Registered AddressCayman Islands
Chairmanshiang huang
Secretaryhaijielimeiyi chai
Audit InstitutionErnst & Young
Company CategoryOverseas registration of Mainland Individuals control
Registered OfficeP.O. Box 472, 2nd Floor Harbour Place, 103 South Church Street George Town, Grand Cayman KY1-1106 Cayman Islands
Head Office and Principal Place of Business5th Floor, Manulife Plaza, 348 Kwun Tong Road, Kowloon, Hong Kong
Fiscal Year Ends12-31
Employees3193
MarketHong Kong motherboard
Phone(86)4007361666
Fax(86)4007361666
Emailpr@kindstar.com.cn
Business Kangsheng Global Gene Technology Co., Ltd. is a Chinese investment holding company that mainly provides clinical testing services. The company operates nine business divisions. The hematological testing department includes testing services related to blood diseases. The Genetic and Rare Diseases Department includes rare disease testing services. The Infectious Diseases Department includes testing services provided by the Infectious Diseases Department. The oncology department includes tests related to oncological diseases. The neurology department includes neurological disease-related testing services undertaken by the Group. The Department of Gynecology-related Diseases includes gynaecology-related testing services. The COVID-19 related testing department includes COVID-19 related testing services. The Routine Testing Division carries out routine tests for physicians' daily diagnosis. Other departments include R&D project testing services and other other services.

Company Executives

  • Name
  • Position
  • Salary
  • shiang huang
  • Presidencies, CEOs, Executive Director, Chief Medical Officer, Chairman of the Nomination Committee
  • --
  • zanbing tu
  • Executive Director, Chief Operating Officer, Remuneration Committee Members
  • --
  • haijie chai
  • Executive Director, Chief Financial Officer, Director of Wuhan Kangshengda, Kangsheng Investment and Wuhan Haixi, Joint Company Secretary, Authorized Representative
  • --
  • ruijin huang
  • Non-executive Directors, Audit Committee Members
  • --
  • wei peng
  • Non-executive Directors
  • --
  • lu huang
  • Non-executive Directors
  • --
  • shanglong yao
  • Independent Non-Executive Director, Nomination Committee Members
  • --
  • xinping xia
  • Independent Non-Executive Director, Chairman of the Audit Committee, Nomination Committee Members, Remuneration Committee Members
  • --
  • huaming gu
  • Independent Non-Executive Director, Remuneration Committee Chairman, Audit Committee Members
  • --
  • meiyi li
  • Joint Company Secretary, Authorized Representative
  • --
  • jianbing fan
  • Chief Scientific Officer
  • --
Heat List
HK
Overall
Symbol
Price
% Chg

No Data